District court

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lantronix, Inc. of Class Action Lawsuit and Upcoming Deadlines – LTRX

Retrieved on: 
Monday, April 8, 2024
Intelligence, EPS, Internet of things, District court, Internet, Ext, LLP, Transport, Complaint, City, Person, Pomerantz, Action Replay, Court, IOT

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Lantronix, Inc. (“Lantronix” or the “Company”) (NASDAQ: LTRX) and certain officers.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Lantronix, Inc. (“Lantronix” or the “Company”) (NASDAQ: LTRX) and certain officers.
  • To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – VTYX

Retrieved on: 
Monday, April 8, 2024
Prior, Psoriasis, Register, Form, District court, Defendant, News, Ext, LLP, IPO, Security (finance), Inflammation, Plaque, Prospectus, Complaint, File, Pomerantz, Action Replay, Court, Person

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX) and certain officers.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX) and certain officers.
  • To discuss this action, contact Danielle Peyton at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Ventyx is a clinical-stage biopharmaceutical company that develops small-molecule product candidates to address a range of inflammatory diseases.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amylyx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – AMLX

Retrieved on: 
Monday, April 8, 2024
Prior, Apoptosis, ALS, District court, Patient, AMX0035, Amyotrophy, Ext, LLP, Prescription, IBD, Complaint, Pomerantz, Action Replay, Food, Court, Evercore, Person, Pharmaceutical industry

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Amylyx Pharmaceuticals, Inc.  (“Amylyx” or the “Company”) (NASDAQ: AMLX) and certain officers.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Amylyx Pharmaceuticals, Inc.  (“Amylyx” or the “Company”) (NASDAQ: AMLX) and certain officers.
  • To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

NYCB DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against New York Community Bancorp, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Sunday, April 7, 2024
Signature, Telephone, District court, ACL, Defendant, News, NYCB, Complaint, P.C, Assumption, Category, Court, Person

Investors have until April 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until April 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • NYCB is a large commercial-real estate lender in the New York City market area, where it specializes in rent-regulated, non-luxury apartment buildings.
  • NYCB is engaged in several national businesses, including multi-family lending, mortgage originations and servicing, and warehouse lending.
  • On January 31, 2024, before the market opened, NYCB announced its fiscal fourth quarter 2023 financial results.

Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against HireRight Holdings Corporation (HRT)

Retrieved on: 
Saturday, April 6, 2024
Employment, IRS, HireRight, Risk, District court, Lead, CFTC, LLP, COPY, IPO, Prospectus, Complaint, Fraud, HRT, Medicare, Person, Security (finance)

RADNOR, Pa., April 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Middle District of Tennessee against HireRight Holdings Corporation (“HireRight”) ( NYSE: HRT ).

Key Points: 
  • RADNOR, Pa., April 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Middle District of Tennessee against HireRight Holdings Corporation (“HireRight”) ( NYSE: HRT ).
  • The action charges HireRight with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • Kessler Topaz Meltzer & Check, LLP encourages HireRight investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The class action complaint against HireRight, Deutsch v. HireRight Holdings Corporation, et al., Case No.

CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Has Filed A Securities Fraud Class Action Lawsuit Against agilon health, inc.

Retrieved on: 
Saturday, April 6, 2024
Risk, District court, UnitedHealth Group, Defendant, Lead, LLP, COPY, News, IPO, Humana, Hope, Medicare, Court, Register

RADNOR, Pa., April 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).

Key Points: 
  • RADNOR, Pa., April 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

XPONENTIAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Xponential Fitness, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, April 6, 2024
SSS, Vii, Telephone, District court, AUV, Bloomberg Businessweek, Sale, News, P.C, Geisler, Court, Person

Investors have until April 9, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until April 9, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • On this news, the price of Xponential common stock fell more than 37%.
  • There is no cost or obligation to you.

Palo Alto Networks Shareholder Lawsuit Filed By Block & Leviton – Investors Who Have Lost Money Should Contact The Firm

Retrieved on: 
Friday, April 5, 2024
Certification, Block & Leviton, Growth, Palo Alto Networks, Federation, PANW, United States district court, District court, Defendant, News, Complaint

The complaint was brought in United States District Court for the Northern District of California and is captioned Schlaegel v. Palo Alto Networks, Inc., et al., No.

Key Points: 
  • The complaint was brought in United States District Court for the Northern District of California and is captioned Schlaegel v. Palo Alto Networks, Inc., et al., No.
  • and is brought on behalf of investors that incurred damages on their purchases in Palo Alto Networks, Inc. securities between August 18, 2023 and February 20, 2024, inclusive.
  • Investors who purchased Palo Alto Networks, Inc. shares between August 18, 2023 and February 20, 2024 and who have lost money are strongly encouraged to contact Block & Leviton attorneys at (617) 398-5600, via email at [email protected] , or to visit our website for information on the case.
  • On this news, the price of Palo Alto Networks, Inc. common stock declined by $104.12 per share, or approximately 28%, on February 21, 2024.

SNOW Litigation Report: Levi & Korsinsky, LLP Provides Investors Further Information on Lawsuit Against Snowflake Inc.

Retrieved on: 
Friday, April 5, 2024
Organization, Growth, Data science, District court, United States district court, Snowflake Inc., LLP, SNOW, Court, Data, Prospectus

They are now seeking compensation for financial losses incurred upon public revelation of the Company’s alleged misconduct during that time.

Key Points: 
  • They are now seeking compensation for financial losses incurred upon public revelation of the Company’s alleged misconduct during that time.
  • Snowflake (NYSE:SNOW) engages in the provision of a data cloud platform.
  • Specifically, they are accused of omitting truthful information about the Company’s growth and revenue from SEC filings and related material.
  • By knowingly or recklessly doing so, they allegedly caused Snowflake stock to trade at artificially inflated prices during the time in question.

Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions

Retrieved on: 
Thursday, April 4, 2024
Documentation, Agreement, District court, Settlement, Annual report, Hearing, Del, Insurance

Tenn.); (2) In re: Clover Health Investments Corp.

Key Points: 
  • Tenn.); (2) In re: Clover Health Investments Corp.
  • (collectively the "Shareholder Derivative Actions").
  • The Shareholder Derivative Actions were filed in the wake of the Company's de-SPAC transaction.
  • As previously disclosed, on February 5, 2024, the plaintiffs in the Shareholder Derivative Actions, on the one hand, and the Company, on the other hand, executed a Stipulation and Agreement of Settlement dated February 2, 2024 (the "Stipulation"), which, subject to final court approval, provides the defendants in the Shareholder Derivative Actions with customary releases and, as previously disclosed, will require the Company to implement a suite of corporate governance enhancements (the "Settlement").